169 related articles for article (PubMed ID: 21323895)
1. 20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.
Liang CJ; Tseng CP; Yang CM; Ma YH
Br J Pharmacol; 2011 Jun; 163(4):815-25. PubMed ID: 21323895
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
Grau R; Punzón C; Fresno M; Iñiguez MA
Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
[TBL] [Abstract][Full Text] [Related]
3. 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta.
Liang CJ; Ives HE; Yang CM; Ma YH
J Lipid Res; 2008 Jan; 49(1):66-73. PubMed ID: 17916879
[TBL] [Abstract][Full Text] [Related]
4. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.
Krönke G; Kadl A; Ikonomu E; Blüml S; Fürnkranz A; Sarembock IJ; Bochkov VN; Exner M; Binder BR; Leitinger N
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1276-82. PubMed ID: 17413033
[TBL] [Abstract][Full Text] [Related]
5. CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.
Chava KR; Karpurapu M; Wang D; Bhanoori M; Kundumani-Sridharan V; Zhang Q; Ichiki T; Glasgow WC; Rao GN
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):809-15. PubMed ID: 19342597
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
Taketa K; Matsumura T; Yano M; Ishii N; Senokuchi T; Motoshima H; Murata Y; Kim-Mitsuyama S; Kawada T; Itabe H; Takeya M; Nishikawa T; Tsuruzoe K; Araki E
J Biol Chem; 2008 Apr; 283(15):9852-62. PubMed ID: 18208815
[TBL] [Abstract][Full Text] [Related]
8. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
9. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
[TBL] [Abstract][Full Text] [Related]
10. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Wu L; Wang W; Dai M; Li H; Chen C; Wang D
BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
13. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
14. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
[TBL] [Abstract][Full Text] [Related]
15. Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Ding S; Huang J; Qiu H; Chen R; Zhang J; Huang B; Cheng O; Jiang Q
Exp Cell Res; 2019 Sep; 382(1):111455. PubMed ID: 31163124
[TBL] [Abstract][Full Text] [Related]
16. PKC-delta/c-Src-mediated EGF receptor transactivation regulates thrombin-induced COX-2 expression and PGE(2) production in rat vascular smooth muscle cells.
Hsieh HL; Sun CC; Wang TS; Yang CM
Biochim Biophys Acta; 2008 Sep; 1783(9):1563-75. PubMed ID: 18452714
[TBL] [Abstract][Full Text] [Related]
17. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
[TBL] [Abstract][Full Text] [Related]
18. 20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells.
Stec DE; Gannon KP; Beaird JS; Drummond HA
Cell Physiol Biochem; 2007; 19(1-4):121-8. PubMed ID: 17310106
[TBL] [Abstract][Full Text] [Related]
19. 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition.
Lakhkar A; Dhagia V; Joshi SR; Gotlinger K; Patel D; Sun D; Wolin MS; Schwartzman ML; Gupte SA
Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1107-17. PubMed ID: 26921441
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4.
Kintscher U; Lyon C; Wakino S; Bruemmer D; Feng X; Goetze S; Graf K; Moustakas A; Staels B; Fleck E; Hsueh WA; Law RE
Circ Res; 2002 Nov; 91(11):e35-44. PubMed ID: 12456495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
